Cargando…
Repeated treatments with rituximab in a patient with amyloid-like IgM deposition neuropathy
Autores principales: | Kadoya, Masato, Kadoya, Akiko, Onoue, Hiroyuki, Ikewaki, Katsunori, Shimizu, Jun, Kaida, Kenichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821664/ https://www.ncbi.nlm.nih.gov/pubmed/27088116 http://dx.doi.org/10.1212/NXI.0000000000000220 |
Ejemplares similares
-
An Atypical Phenotype of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated with Ocular Palsy, IgM-anti Ganglioside Antibody, and Fever-induced Recurrence
por: Horiuchi, Midori, et al.
Publicado: (2021) -
Obinutuzumab, a potent anti–B-cell agent, for rituximab-unresponsive IgM anti-MAG neuropathy
por: Rakocevic, Goran, et al.
Publicado: (2018) -
Discrete renal deposition of IgM heavy chain and κ light chain in Waldenström macroglobulinemia (IgM-κ)
por: Komatsuda, Atsushi, et al.
Publicado: (2012) -
Chemoimmunotherapy with rituximab, cyclophosphamide and prednisolone in IgM paraproteinemic neuropathy: evidence of sustained improvement in electrophysiological, serological and functional outcomes
por: Colchester, Nancy T. H., et al.
Publicado: (2020) -
Granulomatous myositis induced by anti–PD-1 monoclonal antibodies
por: Uchio, Naohiro, et al.
Publicado: (2018)